Ikaros Cancer Vaccines
Ikaros Cancer Vaccines

16.12.28R. Analysis of the NeuVax, (or “E75”), Phase III Trial results presented by GALE in, its 3rd Quarter, 2016, (or “GALE Q3”)

Contact Us

Ikaros Cancer Vaccines
Tartan Lane 4062 
Houston, TX 77025

 

Email:  info@ikaroscancervaccines.com

Print Print | Sitemap
© Ikaros Cancer Vaccines